SAFE MULTIDISCIPLINARY MANAGEMENT OF NEW THERAPIES: THE RITMO PROJECT (REAL TIME CONTINUOUS WEB MONITORING)
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2018)
摘要
Background: Fingolimod is an immunosuppressive drug that prevents the typical autoimmune responses of multiple sclerosis (MS). This drug can cause, even after the first dose, bradycardia and atrioventricular conduction block (AVB). According to a decree of the Committee for Medicinal Products for
更多查看译文
关键词
safe multidisciplinary management,monitoring,new therapies,ritmo project
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要